Uncovering Inequities in Alzheimer’s Disease Screening and Care
January 6, 2026 | AI, Alzhimers Education, Komodo, MAPS, RWE
On December 5, MAPS hosted an educational webinar exploring recent research in Alzheimer’s disease (AD) screening, testing, and treatment. Experts from Komodo Health and Medscape shared findings from their recent joint initiative, which used AI-driven analysis of real-world data to map trends in AD care and reveal where key inequities persist.
While new treatments continue to emerge, significant gaps remain in who gets screened, tested, and treated. Many patients, particularly those in higher-risk groups, still do not receive timely or adequate care.
Key Findings
The analysis found gender-based screening rates reflect national underscreening patterns. The Centers for Disease Control and Prevention data shows only 47% of primary care physicians routinely assess cognitive function in patients age 65 years and older. Men and women are screened at similar rates, yet diagnosis rates differ sharply: 2,620 per 100,000 for females vs1,687 per 100,000 for males.
Racial disparities also surfaced. Black patients, who made up 10% of Alzheimer’s patients, accounted for only 3% of those treated with the second approved DMT, which suggests missed opportunities for earlier detection and intervention.
The Role of Education
Targeted education, including continuing medical education (CME), is a powerful mechanism for change. In a study evaluating a subset of independent medical education programs, clinicians who participated showed an increase in new AD diagnoses that was 1.6x greater than matched controls.1 Post-learning in confidence correlated with real-world behavior change, reinforcing confidence as an early predictor of improved practice.^1
The Growing Need for Action
Today, 7.2 million people in the United States are affected by Alzheimer’s disease, and this number is expected to rise to nearly 13 million by 2050. Globally, that figure is expected to reach 152 million. In this rapidly evolving landscape, clinician education will remain essential to improving awareness of emerging therapies, screening recommendations, and care pathways. As the leading provider of CME for healthcare professionals, Medscape will continue to drive educational initiatives that support earlier detection and more equitable care for all patients affected by AD.
To access the on-demand webinar please visit: https://medicalaffairs.org/webinar-harnessing-ai-and-real-world-evidence-to-advance-alzheimers-screening/
For a full scope on Medscape and Komodo’s Alzheimer’s research please visit: https://education.medscape.org/advancing-alzheimers-equitable-access-with-ai-rwe-maps
*Please note: The webinar is free for MAPS members, a fee for non-members.
About Medscape
Medscape is the leading clinical resource for physicians and healthcare professionals, delivering trusted medical news, evidence-based information, and point-of-care tools—now accelerated by AI. Serving specialists, primary care physicians, and the broader healthcare community, Medscape combines authoritative medical intelligence with powerful educational and clinical decision support tools. Medscape Education (medscape.org) is the premier destination for continuous professional development, offering 30+ specialty-focused channels with thousands of free CME and CE courses. Medscape is a subsidiary of WebMD Health Corp.
About Komodo Health
Komodo Health is a technology platform company creating the new standard for real-world data and analytics by pairing the industry’s most complete view of patient encounters with enterprise software and machine learning to connect the dots between individual patient journeys and large-scale health outcomes. Across Life Sciences, payers, providers, and developers, Komodo helps its customers unearth patient-centric insights at scale — marrying clinical data with advanced algorithms and AI-powered software solutions to inform decision-making, close gaps in care, address disease burden, and help enterprises create a more cost-effective, value-driven healthcare system. For more information, visit Komodohealth.com.
To see more articles like this, follow Komodo Health on X, LinkedIn, or YouTube, and visit Perspectives on their website. Follow Medscape Education on Xand LinkedIn.
For more information about this research, contact Katie Lucero, PhD, at Klucero@medscape.net.
This content was provided by Medscape Education
Company Details
Latest Content from Medscape Education
The Power of Disease Awareness in Infectious Disease Education at IDWeek 2023
Medscape Education had one of its biggest conferences of the year with IDWeek 2023, hosting six educational symposia and presenting five scientific posters highlighting the outcomes of recent infectious disease...
Hear From Her: Announcing The Women in Healthcare Leadership Series Podcast
On the 8th November 2023, Medscape will launch the first episode of their new podcast: the Women in Healthcare Leadership Podcast Series.This insightful series was designed to elevate and empower...
Medscape Education Invites Listeners to ‘Hear From Her’ With New Women in Healthcare Leadership Podcast Series
Medscape Education has launched their new podcast: the Women in Healthcare Leadership Podcast Series. The series, hosted by Medscape Education employees, features women in leadership roles across industry as well...
Sharing Outcomes in MS at ECTRIMS 2023
During ECTRIMS 2023 congress, the Medscape Education Global team will be on site to present a poster of their educational outcomes.The poster, Virtual Patient Simulation Improves Neurologists’ Performance in Making...
Shining a Light on Current Topics in Oncology
The Medscape Oncology team will be on the road again, this time in Madrid, Spain for ESMO 2023. This year, the team will be sharing education with a deep impact...
Disseminating Outcomes and Impact in Berlin
The Medscape Education Global team is looking forward to a busy time in Berlin at the EADV Congress 2023. During the congress, Medscape will be presenting five posters examining the...
Medscape Education’s Large Presence at IDWeek 2023
Medscape are powering education and disease state awareness in infectious diseases at #IDWeek 2023
Contagious Conversations: Exploring Infectious Disease in the Digital Age
As the world of medicine continues to evolve, it's crucial to stay ahead of the curve. In this dynamic era, digital communications have emerged as a driving force in discussions...
Presenting Outstanding Outcomes from HCP Education in Multiple Myeloma at IMS in Athens
From September 27-30, members of the Medscape Education Global team were in Athens, Greece sharing 5 posters at the International Myeloma Society Annual Meeting, 2023.The posters presented the outcomes and...
Impacting Lives with Rare Disease Education
Education on rare diseases is crucial. Estimates suggest there are approximately 10,000 rare diseases, with 263–446 million people affected worldwide.Since its launch in September 2022, the Medscape Pathways in Rare...